Search Result "relapsing-remitting multiple sclerosis."

Experimental Models of Relapsing-Remitting Multiple Sclerosis: Current Concepts and Perspective

Journal: Current Neurovascular Research
Volume: 2 Issue: 4 Year: 2005 Page: 349-362
Author(s): D. S. Skundric

Review Article

Relapsing Remitting Multiple Sclerosis and its Relationship with the Immune System and Oxidative Stress

Journal: Current Immunology Reviews
Volume: 14 Issue: 1 Year: 2018 Page: 15-23
Author(s): Ada Paloma Soto-Brambila,Genaro Gabriel Ortiz,Paloma Rivero-Moragrega,Ana Laura Briones-Torres,Luis Javier Gonzalez-Ortiz,Fermin Paul Pacheco-Moises

Emerging Therapies in Relapsing-Remitting Multiple Sclerosis

Journal: Reviews on Recent Clinical Trials
Volume: 5 Issue: 3 Year: 2010 Page: 179-188
Author(s): James J. Marriott, Paul W. OConnor

Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 3 Year: 2016 Page: 4876-4880
Author(s): Begona M. Escribano, Macarena Aguilar-Luque, Carmen Bahamonde, Cristina Conde, Rafael Lillo, Fernando Sanchez-Lopez, Ana I. Giraldo, Antonio H. Cruz, Evelio Luque, Felix Gascon, Eduardo Aguera, Isaac Tunez

Oral Agents in Multiple Sclerosis

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2015 Page: 15-25
Author(s): L. Lorefice, G. Fenu, J. Frau, G.C. Coghe, M.G. Marrosu, E. Cocco

Multiple Sclerosis: Current and Future Treatment Options

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 7 Issue: 4 Year: 2007 Page: 292-299
Author(s): S. Rizvi

Effect of Glatiramer Acetate on Peripheral Blood Brain-Derived Neurotrophic Factor and Phosphorylated TrkB Levels in Relapsing- Remitting Multiple Sclerosis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 4 Year: 2014 Page: 647-651
Author(s): Vitalie Vacaras, Zsigmond Z. Major, Dafin F. Muresanu, Tibor L. Krausz, Ioan Marginean, Dana A. Buzoianu

Clinical Trials in Relapsing-Remitting Multiple Sclerosis /A New Proposal for Dealing with Basic Problems and Restrictions/

Journal: Reviews on Recent Clinical Trials
Volume: 6 Issue: 3 Year: 2011 Page: 256-258
Author(s): Mieczyslaw Wender, Grazyna Michalowska-Wender

Monoclonal Antibodies in the Treatment of Multiple Sclerosis

Journal: Current Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2009 Page: 4858-4868
Author(s): F. Di Pauli, T. Berger, M. Reindl

Multiple Sclerosis: Pathogenesis and Treatment

Journal: Current Neuropharmacology
Volume: 9 Issue: 3 Year: 2011 Page: 409-416
Author(s): Ingrid Loma, Rock Heyman

Previous   Next

Go To   Results 1 - 1 of 510

Filter Result

Volume Year
© 2022 Bentham Science Publishers | Privacy Policy